Alternatives to Sylentis
The top Biotech companies similar to Sylentis, ranked by relevance (named competitors first, then how closely their sectors overlap) and our 0-100 AI-readiness score. Each links to a full profile with funding and team.
- Website
Rocket Pharmaceuticals58BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
Amgen85BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
BeiGene67BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Amicus Therapeutics63BiotechPhiladelphia, United States$200.0MBiotechnology company focused on developing treatments for rare metabolic diseases.
- Website LELexeo Therapeutics63BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Synthace62BiotechLondon, United Kingdom$60.6MSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Harmony Biosciences Holdings57BiotechPlymouth Meeting, United States$400.5MBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website
Tenaya Therapeutics56BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website ULUltragenyx55BiotechNovato, United States$100.0M
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
- Website
Regenxbio55BiotechRockville, United States$180.0MClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
- Website CECellcolabs55BiotechTel Aviv, Israel$15.5M
AI-powered platform for personalized cell therapy development and manufacturing.
- Website
Alector54BiotechSouth San Francisco, United States$162.5MBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
- Website
BioLife Solutions53BiotechBothell, United States$96.4MDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
- Website
Syantra53BiotechCalgary, Canada$3.6MA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
- Website
PhosPrint53BiotechAthens, Greece$1.0MBiotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.
- Website
Tharimmune53BiotechCambridge, United States$540.0MBiotechnology company developing novel immunotherapies for cancer.
- Website
Rezolute53BiotechRedwood City, United States$220.0MBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
- Website
Bluebird Bio51BiotechSomerville, United States$1.0BGene therapy company developing transformative treatments for severe genetic diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website
Ferring Pharmaceuticals50BiotechSaint-Prex, Switzerland$570.0MA global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.
- Website RIRidge Bio50BiotechSan Francisco, United States$135.0M
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
- Website
Leap Therapeutics50BiotechCambridge, United States$189.0MLeap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.
- Website
Adicet Bio49BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website MAMacroGenics49BiotechRockville, United States$13.5M
Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
- Website TRTreeline Biosciences47BiotechCambridge, United States$200.0M
Developing novel therapeutics for challenging diseases using advanced biological insights.
- Website JUJuvenescence Ltd.47BiotechGeorge Town, Cayman Islands$150.0M
Biotech company focused on developing therapies to extend human healthspan and lifespan.
- Website
Metly46BiotechNew York, United States$2.7MMetly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.
- Website
iSpecimen .46BiotechPlainsboro, United States$1.0MGlobal marketplace connecting researchers with human biospecimens for life science research.
- Website
Lift Biosciences46BiotechCambridge, United Kingdom$18.0MDeveloping advanced cell culture media and bioprocessing solutions for cell and gene therapy.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
Phagos45BiotechBoston, United States$28.5MPhagos is developing bacteriophage therapies to combat antibiotic-resistant bacterial infections.
- Website ALAlpha9 Theranostics44BiotechVancouver, Canada$10.0M
Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.
- Website
VISEN Pharmaceuticals43BiotechSan Diego, United States$200.0MVISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.
- Website
Alto Neuroscience43BiotechLos Altos, United States$370.0MAlto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
AbCellera41BiotechVancouver, Canada$10.0MAI-powered platform for antibody discovery and development to create new medicines.
- Website INIntellia Therapeutics40BiotechCambridge, United States$310.0M
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
CureVac40BiotechTübingen, Germany$2.1BBiopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.
- Website
Lutris Pharma39BiotechSan Diego, United States$170.0MLutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.
- Website RHRhythm Pharmaceuticals61BiotechBoston, United States
Biopharmaceutical company focused on rare genetic diseases of obesity.
- Website
Tahoe Therapeutics36BiotechSan Mateo, United States$31.5MDeveloping novel therapies for neurological disorders.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
EyeGate Pharmaceuticals32BiotechWaltham, United States$45.5MClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
- Website
Red Light Holland .31BiotechToronto, Canada$10.0MCanadian company operating in the legal psilocybin industry, focusing on cultivation, production, and distribution of psilocybin products.
- Website DEDenali Therapeutics70BiotechSouth San Francisco, United States$1.0B
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Cradle69BiotechAmsterdam, Netherlands$102.4MCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
- Website
BioAge Labs53BiotechNew Haven, United StatesBioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Hexagon Bio62BiotechMenlo Park, United States$100.0MDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- Website SASana Biotechnology47BiotechSeattle, United States
Biotechnology company developing cell and gene therapies for serious diseases.
- Website
Moleculent61BiotechStockholm, Sweden$46.0MMapping cell-cell communication at scale in human tissue.
- Website
LabGenius Therapeutics61BiotechLondon, United Kingdom$3.0MAI-driven drug discovery platform for rapid development of novel therapeutics.
- Website
Iambic Therapeutics61BiotechSan Diego, United States$50.0MAI-driven drug discovery company developing novel medicines for unmet patient needs.
- Website
Tekhnovo46BiotechHollister, United KingdomTeknova provides critical reagents for biopharmaceutical product development and production.
- Website
Seqera Labs46BiotechBarcelona, SpainCloud-native platform for scalable and reproducible bioinformatics workflows.